268 related articles for article (PubMed ID: 15637766)
1. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
Jia L; Zhang MH; Yuan SZ; Huang WG
World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of TNP-470 in combination with BCNU on tumor growth of human glioblastoma xenografts.
Yao D; Zhao H; Zhang F; Chen J; Jiang X; Zhu X
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):757-61. PubMed ID: 21181367
[TBL] [Abstract][Full Text] [Related]
5. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice.
Huang ZH; Fan YF; Xia H; Feng HM; Tang FX
World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.
Conrad C; Ischenko I; Köhl G; Wiegand U; Guba M; Yezhelyev M; Ryan AJ; Barge A; Geissler EK; Wedge SR; Jauch KW; Bruns CJ
Anticancer Drugs; 2007 Jun; 18(5):569-79. PubMed ID: 17414626
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of angiogenesis inhibitor TNP-470 on human ACHN renal cell carcinoma.
Zeng J; Mei W; Huang H; Li X; Kong P
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):331-3. PubMed ID: 12674772
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine.
Wang XF; Tu LF; Wang LH; Zhou JY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):837-43. PubMed ID: 16972327
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.
Solorzano CC; Baker CH; Bruns CJ; Killion JJ; Ellis LM; Wood J; Fidler IJ
Cancer Biother Radiopharm; 2001 Oct; 16(5):359-70. PubMed ID: 11776753
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
13. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.
Baker CH; Solorzano CC; Fidler IJ
Cancer Res; 2002 Apr; 62(7):1996-2003. PubMed ID: 11929816
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
Konno H; Tanaka T; Matsuda I; Kanai T; Maruo Y; Nishino N; Nakamura S; Baba S
Int J Cancer; 1995 Apr; 61(2):268-71. PubMed ID: 7535757
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
Xia JL; Yang BH; Tang ZY; Sun FX; Xue Q; Gao DM
J Cancer Res Clin Oncol; 1997; 123(7):383-7. PubMed ID: 9260590
[TBL] [Abstract][Full Text] [Related]
16. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
Xu G; Wu K; Wang XP; Zhao S
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
Takei H; Lee ES; Cisneros A; Jordan VC
Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of fumagillol combined with cyclophosphamide on metastasis of lung adenocarcinoma cell line LA795 xenograft in mice].
Wang XH; Wang Z; Duan BC; Song JT; He JB; Ou LW; Zhang P
Ai Zheng; 2005 Dec; 24(12):1448-52. PubMed ID: 16351790
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy.
Konno H
Cancer Chemother Pharmacol; 1999; 43 Suppl():S85-9. PubMed ID: 10357565
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
Teicher BA; Holden SA; Dupuis NP; Kakeji Y; Ikebe M; Emi Y; Goff D
Breast Cancer Res Treat; 1995; 36(2):227-36. PubMed ID: 8534870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
